Exactly one year ago tomorrow, the [tag]House[/tag] easily passed [tag]bi-partisan[/tag] legislation that would remove restrictions on embryonic [tag]stem cell research[/tag]. The companion measure in the [tag]Senate[/tag] had a filibuster-proof majority, Bill Frist endorsed the bill and vowed to bring it to the floor, and [tag]polls[/tag] showed overwhelming support from the public. Newsweek’s Jonathan Alter wrote at the time, “Unless there’s another war, stem cells will become one of the defining issues of the 2006 [tag]campaign[/tag].”
It seemed we were finally on the brink of a breakthrough for science, medical research, and public health. And then … nothing. Frist came around on the policy, but hasn’t done anything about it. Now, there’s a growing consensus that the nation has waited long enough.
A full year after the House passed legislation that would loosen President Bush’s restrictions on human [tag]embryonic[/tag] [tag]stem cell[/tag] research, the Senate is coming under intense pressure to tackle the controversial bill — in the awkward new context of an election year.
The legislation, which Bush has repeatedly threatened to veto, would allow the National Institutes of Health to fund research on human embryos slated for destruction at fertility clinics. It is backed by science and patient-advocacy groups, and was endorsed by Senate Majority Leader Bill Frist (R-Tenn.) last summer, when momentum behind the research was at a peak.
But the political calculus around stem cells has changed in unexpected ways since then, raising questions about how Frist can fulfill his promises to bring the bill to a vote without weakening his appeal to conservatives as he considers a 2008 presidential run.
To a certain extent, one could make an argument that there’s no hurry. The [tag]Bush[/tag] [tag]White House[/tag] has vowed to veto the legislation, so there’s little incentive to hurry up to watch the bill get killed. On the other hand, it’s just as likely the president might change his mind — he’s failed to follow through on veto threats before (transportation bill, McCain/Feingold), there’s a little wiggle room in Bush’s threat, and a [tag]veto[/tag] would hand the [tag]Democrats[/tag] a powerful issue in a campaign year that’s already going in their direction. There’s even an outside chance that there are enough votes to overturn a veto on this issue.
In the meantime, the pressure is about to heat up considerably.
The Coalition for the Advancement of Medical Research (CAMR) will hold a press event this morning in the park next to the Russell Senate Office Building that will feature patients stricken with ailments that, research supporters maintain, could be treated with therapies developed using the science.
The patients and CAMR representatives will be joined at the event by the bipartisan group of lawmakers who have pushed the bill in both chambers.
The office of Rep. Mike Castle (R-Del.) said yesterday that he and Rep. Diana DeGette (D-Colo), the House bill’s sponsors, will be there with Sens. Arlen Specter (R-Pa.), Orrin Hatch (R-Utah), Gordon Smith (R-Ore.), Tom Harkin (D-Iowa), Edward Kennedy (D-Mass.) and Dianne Feinstein (D-Calif.).
For that matter, those who read the New York Times print edition may have noticed yesterday that the Campaign to Defend the Constitution took out a full-page ad (.pdf) yesterday arguing that the legislation has been “held hostage by religious extremists who hold enormous sway over Majority Leader Bill Frist.” The ad’s headline reads, “Meet America’s most influential stem cell [tag]scientists[/tag],” which then shows pictures of [tag]Pat Robertson[/tag], [tag]Jerry Falwell[/tag], and [tag]James Dobson[/tag].
I know there are plenty of issues to consider in a campaign context, but I still believe stem-cell research has such broad bi-partisan support, Dems would be foolish to let this opportunity slip away. Bush and the GOP base are standing in the way of a [tag]public health[/tag] breakthrough. The more Dems remind voters of this, the better.